Ameritas Investment Partners’s GSK GSK Stock Holding History

Ameritas Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-137	Closed	-$6K	–	3087
2020 Q3	$6K	Buy	+137	New	+$6.86K	﹤0.01%	2917
2018 Q1	–	Sell	-685	Closed	-$2K	–	2960
2017 Q4	$2K	Hold	685	–	–	﹤0.01%	2931
2017 Q3	$34K	Hold	685	–	–	﹤0.01%	2102
2017 Q2	$36K	Hold	685	–	–	﹤0.01%	2106
2017 Q1	$36K	Hold	685	–	–	﹤0.01%	2048
2016 Q4	$32K	Sell	685 -132	-16%	-$6.52K	﹤0.01%	1142
2016 Q3	$44K	Hold	817	–	–	﹤0.01%	1105
2016 Q2	$44K	Hold	817	–	–	﹤0.01%	1038
2016 Q1	$41K	Hold	817	–	–	﹤0.01%	1038
2015 Q4	$41K	Buy	817 +685	+519%	+$34.9K	﹤0.01%	1033
2015 Q3	$6K	Hold	132	–	–	﹤0.01%	1094
2015 Q2	$6K	Hold	132	–	–	﹤0.01%	1147
2015 Q1	$7K	Hold	132	–	–	﹤0.01%	1183
2014 Q4	$7K	Buy	+132	New	+$7.38K	﹤0.01%	1162
2014 Q1	–	Sell	-29,040	Closed	-$1.94M	–	1073
2013 Q4	$1.94M	Hold	29,040	–	–	0.15%	168
2013 Q3	$1.82M	Hold	29,040	–	–	0.17%	158
2013 Q2	$1.81M	Buy	+29,040	New	+$1.84M	0.5%	76

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Ameritas Investment Partners's GSK Position: Q4 2020 in Review

Ameritas Investment Partners sold out of GSK (GSK) in Q4 2020, closing a stake of 137 shares — an estimated $6K sold.

Ameritas Investment Partners first reported a position in GSK in Q2 2013 and held it in 17 quarters. The position peaked at $1.94M in Q4 2013. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Ameritas Investment Partners reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Ameritas Investment Partners sold 137 GSK shares in Q4 2020, an estimated $6K.
Ameritas Investment Partners first reported a position in GSK in Q2 2013 and held it in 17 quarters.
Ameritas Investment Partners's GSK position peaked at $1.94M in Q4 2013.
818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Ameritas Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.